NewLink Genetics Corp. Company Profile (NASDAQ:NLNK)

About NewLink Genetics Corp.

NewLink Genetics Corp. logoNewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic product candidates are based on its HyperAcute immunotherapy technology platform, which is designed to stimulate the human immune system. Algenpantucel-L is its clinically advanced product candidate for patients with pancreatic cancer. Its additional HyperAcute cellular HyperAcute Cellular Immunotherapy product candidates in clinical development include tergenpumatucel-L and dorgenmeltucel-L for patients with advanced lung cancer and melanoma. It has two small-molecule product candidates in clinical development: GDC-0919 and indoximod. These product candidates are indoleamine-2, 3-dioxygenase (IDO) pathway inhibitors and focus on breaking the immune system's tolerance to cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: NLNK
  • CUSIP: 65151110
Key Metrics:
  • Previous Close: $12.87
  • 50 Day Moving Average: $10.57
  • 200 Day Moving Average: $12.98
  • 52-Week Range: $28,969,000.00 - $9.23
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.94
  • P/E Growth: 0.00
  • Market Cap: $372.83M
  • Outstanding Shares: 28,969,000
  • Beta: 1.13
Profitability:
  • Net Margins: -316.38%
  • Return on Equity: -51.33%
  • Return on Assets: -45.39%
Debt:
  • Current Ratio: 7.63%
  • Quick Ratio: 7.63%
Additional Links:
Companies Related to NewLink Genetics Corp.:

Analyst Ratings

Consensus Ratings for NewLink Genetics Corp. (NASDAQ:NLNK) (?)
Ratings Breakdown: 2 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $25.00 (94.25% upside)
Analysts' Ratings History for NewLink Genetics Corp. (NASDAQ:NLNK)
Show:
DateFirmActionRatingPrice TargetDetails
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details
5/11/2016Jefferies GroupReiterated RatingHold$10.00View Rating Details
5/10/2016SunTrust Banks Inc.DowngradeBuy -> Neutral$59.00 -> $12.00View Rating Details
5/10/2016MizuhoLower Price TargetBuy$52.00 -> $20.00View Rating Details
5/10/2016Stifel NicolausLower Price TargetBuy$63.00 -> $23.00View Rating Details
4/29/2016Cantor FitzgeraldReiterated RatingBuy$62.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for NewLink Genetics Corp. (NASDAQ:NLNK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
7/29/2016Q216($0.77)($1.12)$5.41 millionViewListenView Earnings Details
4/29/2016Q116($1.70)($0.82)$2.08 million$4.34 millionViewListenView Earnings Details
2/29/2016Q415($0.92)($0.75)$4.89 million$6.06 millionViewListenView Earnings Details
11/3/2015Q315($0.66)($0.55)$6.76 millionViewN/AView Earnings Details
7/31/2015Q215($0.70)($0.49)$4.32 million$7.45 millionViewListenView Earnings Details
5/5/2015Q115($0.22)$0.35$2.32 millionViewN/AView Earnings Details
2/26/2015Q414($0.68)$4.05$2.98 million$159.25 millionViewN/AView Earnings Details
11/6/2014Q314($0.40)($0.20)$2.80 millionViewN/AView Earnings Details
8/5/2014Q214($0.42)($0.33)ViewN/AView Earnings Details
5/6/2014($0.37)($0.33)ViewN/AView Earnings Details
3/11/2014($0.37)($0.31)ViewN/AView Earnings Details
11/11/2013Q3($0.33)($0.32)ViewN/AView Earnings Details
8/7/2013Q213($0.32)($0.28)$0.59 million$0.23 millionViewN/AView Earnings Details
5/6/2013Q113($0.28)($0.33)$0.41 million$0.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NewLink Genetics Corp. (NASDAQ:NLNK)
Current Year EPS Consensus Estimate: $-3.06 EPS
Next Year EPS Consensus Estimate: $-1.62 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.92)($0.87)($0.90)
Q2 20162($0.89)($0.80)($0.85)
Q3 20162($0.84)($0.69)($0.77)
Q4 20162($0.66)($0.59)($0.63)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for NewLink Genetics Corp. (NASDAQ:NLNK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NewLink Genetics Corp. (NASDAQ:NLNK)
Insider Ownership Percentage: 12.00%
Institutional Ownership Percentage: 50.10%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/15/2016Charles J Jr. LinkCEOSell25,000$17.86$446,500.00View SEC Filing  
1/6/2016Charles J. Jr. LinkCEOSell25,000$32.53$813,250.00View SEC Filing  
1/5/2016Brian WileyVPSell1,295$34.99$45,312.05View SEC Filing  
1/5/2016Carl W. LangreninsiderSell1,095$34.97$38,292.15View SEC Filing  
1/5/2016Charles J. Jr. LinkCEOSell5,001$35.06$175,335.06View SEC Filing  
1/5/2016John B. Henneman IIICFOSell175$35.74$6,254.50View SEC Filing  
10/7/2015Charles J. Jr. LinkCEOSell10,000$35.16$351,600.00View SEC Filing  
10/5/2015Charles J. Jr. LinkCEOSell15,000$37.36$560,400.00View SEC Filing  
7/13/2015Joseph SaluriDirectorSell5,000$50.42$252,100.00View SEC Filing  
7/6/2015Charles J Jr. LinkCEOSell20,000$44.65$893,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NewLink Genetics Corp. (NASDAQ:NLNK)
DateHeadline
News IconChart of The Day: NewLink Genetics Corp Formed a Multiple Bottom, Could Be One of The Worst Performers Going ... - Chester News (NASDAQ:NLNK)
www.chesterindependent.com - September 19 at 6:25 PM
capitalcube.com logoNewLink Genetics Corp. – Value Analysis (NASDAQ:NLNK) : September 19, 2016 (NASDAQ:NLNK)
www.capitalcube.com - September 19 at 6:25 PM
News IconWhat are Brokerage Firms Saying About NewLink Genetics Corporation (NASDAQ:NLNK)? - Frisco Fastball (NASDAQ:NLNK)
friscofastball.com - September 18 at 5:59 PM
News IconLooking Ahead for NewLink Genetics Corporation (NASDAQ:NLNK); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:NLNK)
friscofastball.com - September 18 at 5:59 PM
capitalcube.com logoNewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : September 16, 2016 (NASDAQ:NLNK)
www.capitalcube.com - September 16 at 9:55 AM
capitalcube.com logoETF’s with exposure to NewLink Genetics Corp. : September 9, 2016 (NASDAQ:NLNK)
www.capitalcube.com - September 9 at 6:04 PM
globenewswire.com logoNewLink Genetics to Participate in Baird Healthcare Conference - GlobeNewswire (press release) (NASDAQ:NLNK)
globenewswire.com - September 3 at 10:45 AM
finance.yahoo.com logoNewLink Genetics to Participate in Baird Healthcare Conference (NASDAQ:NLNK)
finance.yahoo.com - September 1 at 9:36 AM
capitalcube.com logoETF’s with exposure to NewLink Genetics Corp. : August 22, 2016 (NASDAQ:NLNK)
www.capitalcube.com - August 22 at 6:25 PM
News IconStock Tracking Lower for the Quarter: NewLink Genetics Corporation (NASDAQ:NLNK) - Post News (NASDAQ:NLNK)
www.kentuckypostnews.com - August 20 at 6:08 PM
finance.yahoo.com logoNEWLINK GENETICS CORP Financials (NASDAQ:NLNK)
finance.yahoo.com - August 13 at 6:09 PM
capitalcube.com logoETF’s with exposure to NewLink Genetics Corp. : August 8, 2016 (NASDAQ:NLNK)
www.capitalcube.com - August 8 at 6:41 PM
tradecalls.org logoNewLink Genetics Corporation (NLNK) Shares are Up 3.97% - Trade Calls (NASDAQ:NLNK)
www.tradecalls.org - August 8 at 11:10 AM
tradecalls.org logoRevenue Update on NewLink Genetics Corp(NASDAQ:NLNK) - Trade Calls (NASDAQ:NLNK)
www.tradecalls.org - August 7 at 6:05 PM
capitalcube.com logoNewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:NLNK)
www.capitalcube.com - August 5 at 6:39 PM
biz.yahoo.com logoNEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:NLNK)
biz.yahoo.com - August 5 at 6:39 PM
twst.com logoNewLink Genetics Corporation: NewLink Genetics Reports Second Quarter 2016 Financial Results (NASDAQ:NLNK)
www.twst.com - July 30 at 9:19 AM
cnbc.com logoNewLink reports 2Q loss (NASDAQ:NLNK)
www.cnbc.com - July 29 at 6:37 PM
4-traders.com logoNewLink Genetics : reports 2Q loss (NASDAQ:NLNK)
www.4-traders.com - July 29 at 6:37 PM
streetinsider.com logoNewLink Genetics (NLNK) Misses Q2 EPS by 35c; Announces Restructuring Plans (NASDAQ:NLNK)
www.streetinsider.com - July 29 at 6:37 PM
seekingalpha.com logoNewLink Genetics' (NLNK) CEO Charles Link on Q2 2016 Results - Earnings Call Transcript (NASDAQ:NLNK)
seekingalpha.com - July 29 at 6:37 PM
publicnow.com logoNewLink Genetics Reports Second Quarter 2016 Financial Results (NASDAQ:NLNK)
www.publicnow.com - July 29 at 8:28 AM
biz.yahoo.com logoNEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:NLNK)
biz.yahoo.com - July 29 at 8:24 AM
News IconIt's Earnings Time: What to Do with NewLink Genetics Corporation (NASDAQ:NLNK) Stock - The Voice Registrar (NASDAQ:NLNK)
voiceregistrar.com - July 28 at 9:40 AM
zacks.com logoWhy Earnings Season Could Be Great for NewLink Genetics (NLNK) (NASDAQ:NLNK)
www.zacks.com - July 27 at 9:28 AM
streetinsider.com logoNewLink Genetics (NLNK) Announces Achievement of Two Ebola Zaire Vaccine Candidate Milestones by Merck (MRK) (NASDAQ:NLNK)
www.streetinsider.com - July 26 at 9:41 AM
streetinsider.com logoNewLink Genetics (NLNK) Announces Achievement of Two Ebola Zaire Vaccine Candidate Milestones by Merck (MRK) - StreetInsider.com (NASDAQ:NLNK)
www.streetinsider.com - July 25 at 10:54 AM
publicnow.com logoNewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920) (NASDAQ:NLNK)
www.publicnow.com - July 25 at 8:18 AM
capitalcube.com logoNewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : July 22, 2016 (NASDAQ:NLNK)
www.capitalcube.com - July 22 at 8:23 AM
News IconNewLink Genetics Corporation (NASDAQ:NLNK): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:NLNK)
www.engelwooddaily.com - July 21 at 6:45 PM
News IconNewlink Genetics Corporation (NASDAQ:NLNK) Sellers Covered 19.5% of Their Shorts - Consumer Eagle (NASDAQ:NLNK)
www.consumereagle.com - July 21 at 6:45 PM
equities.com logoNewLink Genetics Corporation (NLNK) Drops 5.14% on July 19 - Equities.com (NASDAQ:NLNK)
www.equities.com - July 21 at 6:45 PM
News IconEquity Roundup: Stock Performance Focus on NewLink Genetics Corporation (NASDAQ:NLNK) - Press Telegraph (NASDAQ:NLNK)
presstelegraph.com - July 20 at 9:25 AM
finance.yahoo.com logoNewLink Genetics to Host Its Second Quarter 2016 Financial Results Conference Call on July 29, 2016 (NASDAQ:NLNK)
finance.yahoo.com - July 20 at 7:00 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for NewLink Genetics Corporation (NASDAQ:NLNK) - TGP (NASDAQ:NLNK)
telanaganapress.com - July 19 at 6:36 PM
capitalcube.com logoNewLink Genetics Corp. – Value Analysis (NASDAQ:NLNK) : July 18, 2016 (NASDAQ:NLNK)
www.capitalcube.com - July 18 at 4:04 PM
fiscalstandard.com logoNewLink Genetics Corporation (NLNK) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:NLNK)
www.fiscalstandard.com - July 17 at 10:42 AM
News IconShares Experiencing a Downtrend: NewLink Genetics Corporation (NASDAQ:NLNK) - TGP (NASDAQ:NLNK)
telanaganapress.com - July 15 at 5:29 PM
News IconAnalyst Target and Average Rating Watch: NewLink Genetics Corporation (NASDAQ:NLNK) - Press Telegraph (NASDAQ:NLNK)
presstelegraph.com - July 15 at 11:17 AM
News IconNewLink Genetics Corporation (NASDAQ:NLNK) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:NLNK)
www.engelwooddaily.com - July 15 at 11:17 AM
News IconAre Analysts Bearish NewLink Genetics Corp (NASDAQ:NLNK) After Last Week? - Consumer Eagle (NASDAQ:NLNK)
www.consumereagle.com - July 15 at 11:17 AM
news.cmlviz.com logoNewLink Genetics Corporation (NasdaqGM:NLNK) Fundamental Star Rating Report - CML News (NASDAQ:NLNK)
news.cmlviz.com - July 15 at 11:17 AM
equities.com logoNewLink Genetics Corporation (NLNK) Drops 6.88% on July 13 - Equities.com (NASDAQ:NLNK)
www.equities.com - July 15 at 11:17 AM
News IconCould NewLink Genetics Corp Crash Even More? The Stock Had Another Big Decline Today - Consumer Eagle (NASDAQ:NLNK)
www.consumereagle.com - July 13 at 6:51 PM
News IconNewLink Genetics Corporation (NASDAQ:NLNK) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:NLNK)
telanaganapress.com - July 12 at 10:49 AM
finance.yahoo.com logoDEADLINE TODAY: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm (NASDAQ:NLNK)
finance.yahoo.com - July 11 at 12:32 PM
News IconCoverage Initiated on Select Biotech Equities (NASDAQ:NLNK)
news.investornetwork.com - July 11 at 8:58 AM
capitalcube.com logoNewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : July 11, 2016 (NASDAQ:NLNK)
www.capitalcube.com - July 11 at 8:18 AM
finance.yahoo.com logo72-Hour Deadline Alert: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm (NASDAQ:NLNK)
finance.yahoo.com - July 8 at 11:37 PM
finance.yahoo.com logoNEWLINK 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against NewLink Genetics Corporation - NLNK (NASDAQ:NLNK)
finance.yahoo.com - July 8 at 10:07 PM

Social

NewLink Genetics Corp. (NASDAQ:NLNK) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff